BioDue

Completed Date

2022-11-16

Sector

Healthcare

Deal Type

Company sale

Value

Not disclosed

Company bio

Founded in 1986 by the Benedetti family, BioDue is one of the main Italian players active in the development and production of food supplements and medical devices. The company produces niche formulations to third parties (“CDMO”), with a particular focus on liquids and in the probiotic, respiratory and gastrointestinal segments. BioDue also markets its own brand products in several therapeutic areas, including Pharcos (Dermatology), BiOfta (Ophthalmology), Agex (Aesthetics), River Pharma (Orthopedics) and IP Farma (Gynecology).

Deal Summary

Ethica Group, with the M&A Advisory team, assisted BioDue, an Italian excellence specialized in the development, production and marketing of food supplements, medical devices and cosmetics, already in the Armònia portfolio, in the sale of a majority stake to Riverside, a private equity with a global presence.

Deal Contacts

Giorgio Carere

Giorgio Carere's avatar

Roberto Liguori

Roberto Liguori's avatar

Ethica Group is the exclusive Italian partner of Mergers Alliance

Other Ethica Group Deals

Other Deals